Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Role of Recruitment Processes in Structuring Coralligenous Benthic Assemblages in the Northern Adriatic Continental Shelf.

Fava F, Ponti M, Abbiati M.

PLoS One. 2016 Oct 4;11(10):e0163494. doi: 10.1371/journal.pone.0163494. eCollection 2016.

2.

Genetic hierarchy and temporal variegation in the clonal history of acute myeloid leukaemia.

Hirsch P, Zhang Y, Tang R, Joulin V, Boutroux H, Pronier E, Moatti H, Flandrin P, Marzac C, Bories D, Fava F, Mokrani H, Betems A, Lorre F, Favier R, Féger F, Mohty M, Douay L, Legrand O, Bilhou-Nabera C, Louache F, Delhommeau F.

Nat Commun. 2016 Aug 18;7:12475. doi: 10.1038/ncomms12475.

3.

Genomic and phenotypic characterization of the species Acinetobacter venetianus.

Fondi M, Maida I, Perrin E, Orlandini V, La Torre L, Bosi E, Negroni A, Zanaroli G, Fava F, Decorosi F, Giovannetti L, Viti C, Vaneechoutte M, Dijkshoorn L, Fani R.

Sci Rep. 2016 Feb 23;6:21985. doi: 10.1038/srep21985.

4.

Endothelial protein C receptor gene 6936A/G single-nucleotide polymorphism as a possible biomarker of thrombotic risk in acute myeloid leukemia.

Besbes S, Althawadi H, Alfarsi H, Mirshahi S, Tang R, Fava F, Pardo J, Huessler EM, Galtier T, Ghedira I, Soria J, Marie JP, Mirshahi M.

Mol Clin Oncol. 2015 Nov;3(6):1280-1284. Epub 2015 Sep 8.

5.

The CNGRC-GG-D(KLAKLAK)2 peptide induces a caspase-independent, Ca2+-dependent death in human leukemic myeloid cells by targeting surface aminopeptidase N/CD13.

Bouchet S, Tang R, Fava F, Legrand O, Bauvois B.

Oncotarget. 2016 Apr 12;7(15):19445-67. doi: 10.18632/oncotarget.6523.

6.

The gut microbiota and host health: a new clinical frontier.

Marchesi JR, Adams DH, Fava F, Hermes GD, Hirschfield GM, Hold G, Quraishi MN, Kinross J, Smidt H, Tuohy KM, Thomas LV, Zoetendal EG, Hart A.

Gut. 2016 Feb;65(2):330-9. doi: 10.1136/gutjnl-2015-309990. Epub 2015 Sep 2. Review.

7.

Targeting CD13 (aminopeptidase-N) in turn downregulates ADAM17 by internalization in acute myeloid leukaemia cells.

Bouchet S, Tang R, Fava F, Legrand O, Bauvois B.

Oncotarget. 2014 Sep 30;5(18):8211-22.

8.

Applying ecological and evolutionary theory to cancer: a long and winding road.

Thomas F, Fisher D, Fort P, Marie JP, Daoust S, Roche B, Grunau C, Cosseau C, Mitta G, Baghdiguian S, Rousset F, Lassus P, Assenat E, Grégoire D, Missé D, Lorz A, Billy F, Vainchenker W, Delhommeau F, Koscielny S, Itzykson R, Tang R, Fava F, Ballesta A, Lepoutre T, Krasinska L, Dulic V, Raynaud P, Blache P, Quittau-Prevostel C, Vignal E, Trauchessec H, Perthame B, Clairambault J, Volpert V, Solary E, Hibner U, Hochberg ME.

Evol Appl. 2013 Jan;6(1):1-10. doi: 10.1111/eva.12021. Epub 2012 Nov 16.

9.

Bioaugmentation of a historically contaminated soil by polychlorinated biphenyls with Lentinus tigrinus.

Federici E, Giubilei M, Santi G, Zanaroli G, Negroni A, Fava F, Petruccioli M, D'Annibale A.

Microb Cell Fact. 2012 Mar 23;11:35. doi: 10.1186/1475-2859-11-35.

10.

Prognostic impact of high ABC transporter activity in 111 adult acute myeloid leukemia patients with normal cytogenetics when compared to FLT3, NPM1, CEBPA and BAALC.

Hirsch P, Tang R, Marzac C, Perrot JY, Fava F, Bernard C, Jeziorowska D, Marie JP, Legrand O.

Haematologica. 2012 Feb;97(2):241-5. doi: 10.3324/haematol.2010.034447. Epub 2011 Nov 4.

11.

ATP Binding Cassette transporters associated with chemoresistance: transcriptional profiling in extreme cohorts and their prognostic impact in a cohort of 281 acute myeloid leukemia patients.

Marzac C, Garrido E, Tang R, Fava F, Hirsch P, De Benedictis C, Corre E, Lapusan S, Lallemand JY, Marie JP, Jacquet E, Legrand O.

Haematologica. 2011 Sep;96(9):1293-301. doi: 10.3324/haematol.2010.031823. Epub 2011 May 23.

12.

Obesity and the gut microbiota: does up-regulating colonic fermentation protect against obesity and metabolic disease?

Conterno L, Fava F, Viola R, Tuohy KM.

Genes Nutr. 2011 Aug;6(3):241-60. doi: 10.1007/s12263-011-0230-1. Epub 2011 May 11.

13.

Intestinal microbiota in inflammatory bowel disease: friend of foe?

Fava F, Danese S.

World J Gastroenterol. 2011 Feb 7;17(5):557-66. doi: 10.3748/wjg.v17.i5.557.

14.

Characterization of two diesel fuel degrading microbial consortia enriched from a non acclimated, complex source of microorganisms.

Zanaroli G, Di Toro S, Todaro D, Varese GC, Bertolotto A, Fava F.

Microb Cell Fact. 2010 Feb 16;9:10. doi: 10.1186/1475-2859-9-10.

15.

The path to next generation biofuels: successes and challenges in the era of synthetic biology.

Dellomonaco C, Fava F, Gonzalez R.

Microb Cell Fact. 2010 Jan 20;9:3. doi: 10.1186/1475-2859-9-3. Review.

16.

P-gp activity is a critical resistance factor against AVE9633 and DM4 cytotoxicity in leukaemia cell lines, but not a major mechanism of chemoresistance in cells from acute myeloid leukaemia patients.

Tang R, Cohen S, Perrot JY, Faussat AM, Zuany-Amorim C, Marjanovic Z, Morjani H, Fava F, Corre E, Legrand O, Marie JP.

BMC Cancer. 2009 Jun 23;9:199. doi: 10.1186/1471-2407-9-199.

17.

Isolation and characterisation of polychlorinated biphenyl (PCB) degrading fungi from a historically contaminated soil.

Tigini V, Prigione V, Di Toro S, Fava F, Varese GC.

Microb Cell Fact. 2009 Jan 12;8:5. doi: 10.1186/1475-2859-8-5.

18.

A review on slurry bioreactors for bioremediation of soils and sediments.

Robles-González IV, Fava F, Poggi-Varaldo HM.

Microb Cell Fact. 2008 Feb 29;7:5. doi: 10.1186/1475-2859-7-5.

19.

Vanillin production using metabolically engineered Escherichia coli under non-growing conditions.

Barghini P, Di Gioia D, Fava F, Ruzzi M.

Microb Cell Fact. 2007 Apr 16;6:13.

Supplemental Content

Loading ...
Support Center